Telmisartan Tablet 40 mg (Telmisartan)

Adult dose

Essential hypertension: Administer 40 mg of telmisartan once daily orally with water, and it can be taken regardless of meals. Depending on the patient, 20 mg once daily may be effective, and may be increased up to 80 mg once daily if necessary. The maximum blood pressure lowering effect occurs 4 to 8 weeks after starting treatment. Reduction of cardiovascular disease risk: It is recommended to take 80 mg once daily orally with water.

This medication can cause serious harm to the fetus and newborn if taken during pregnancy, especially in the second and third trimesters, so it should be stopped immediately if pregnancy is confirmed. This medication should not be used in women who are allergic to it, pregnant or breastfeeding women, patients with severe liver disease or cholestasis, patients with a history of certain angioedema, and patients with diabetes or severe renal impairment. It should be used with caution in elderly patients, those with high potassium levels, patients with mild to moderate liver impairment, those with heart valve diseases or cardiovascular diseases, patients with gastrointestinal diseases, renal artery hypertension patients, and patients with severely impaired kidney function. While taking this medication, side effects such as low blood pressure, dizziness, angioedema, hyperkalemia, worsening renal function, liver function abnormalities, and difficulty breathing may occur. If any symptoms appear, consult a doctor immediately. When taken with other antihypertensives, this medication may increase the blood pressure lowering effect or affect renal function, so blood pressure and renal function, as well as electrolyte levels should be regularly monitored when used in combination. Particularly, caution is needed when taken with lithium, certain diuretics, potassium-sparing diuretics, and non-steroidal anti-inflammatory drugs (NSAIDs) as the risk of side effects may increase. Patients scheduled for surgery should ideally stop taking this medication 24 hours before the procedure and should be cautious of dizziness or fainting risks while driving or operating machinery. Safety and efficacy have not been established in children and adolescents under 18 years, so it is not recommended. In the case of overdose, symptoms such as hypotension, tachycardia, dizziness, and acute renal failure may occur, and appropriate treatment should be sought immediately at a medical facility. This medication should be kept out of the reach of children and should not be opened until right before use.

Serious side effects

Hives, severe swelling (edema), chest tightness, difficulty breathing, cold sweat, pallor, severe allergic reactions, severe rashes with high fever, blisters, peeling skin, pain in the mucous membranes of the mouth/eyes, severe skin reactions, shortness of breath or difficulty breathing, asthma attacks, respiratory abnormalities with cough and fever, respiratory problems, jaundice (yellowing of the skin or eyes), profound lethargy, liver abnormalities (jaundice), sudden and

Mild side effects

• Upper respiratory infection
• pharyngitis
• sinusitis
• urinary tract infection
• cystitis
• anemia
• thrombocytopenia
• eosinophilia
• hypersensitivity
• hyperkalemia

This medication should be stored in a tightly sealed container to prevent exposure to air and moisture. It is important to keep the storage temperature between 1 and 30 degrees Celsius to maintain the efficacy of the medication.

Appearance

White or off-white oval tablet

Package unit

30 tablets (10 tablets/PTPX3)